Diosgenin decreases gestational diabetes in db/ + pregnant mice, by improvements in glucose and insulin resistance, a decline in fasting blood glucose and insulin levels, and an increase in hepatic glycogen content. This evidence concerns the gene INS and gestational diabetes.